Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia, Unilabs Partner to Advance Use of AI in High-Throughput Diagnostic Workflows

Proscia
By Author Proscia | April 7, 2021

Philadelphia-based Proscia and Stockholm-based Unilabs have established a strategic partnership to accelerate the adoption of artificial intelligence (AI) in routine pathology practice. Through the collaboration, Unilabs will validate the efficacy of Proscia’s computational pathology applications and deploy them into its high-throughput workflows, improving diagnostic quality and reducing turnaround times to directly benefit patients and the physicians treating them.

Our website uses cookies. By using this site, you agree to its use of cookies.